A new RNA-based therapy aims to address one of cardiology’s most persistent challenges: the heart’s inability to regenerate after injury. After a heart attack, restoring blood flow is often only part of the battle. Even when blocked arteries are reopened,…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.